{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:57:28Z","timestamp":1781690248026,"version":"3.54.5"},"reference-count":44,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303590"],"award-info":[{"award-number":["82303590"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Innovation Team Development Program of Shandong Province","award":["2023KJ227"],"award-info":[{"award-number":["2023KJ227"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025T180977"],"award-info":[{"award-number":["2025T180977"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M741867"],"award-info":[{"award-number":["2023M741867"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postdoctoral Innovation Program of Shandong Province","award":["SDCX-ZG-202400078"],"award-info":[{"award-number":["SDCX-ZG-202400078"]}]},{"DOI":"10.13039\/100018936","name":"Qingdao Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["QDBSH20230202076"],"award-info":[{"award-number":["QDBSH20230202076"]}],"id":[{"id":"10.13039\/100018936","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2026.2686919","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:24:50Z","timestamp":1781688290000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis, and biological evaluation of 6-aryl-3-(3,4,5-trimethoxyphenyl)imidazo[1,2-a]pyridine derivatives as novel tubulin inhibitors with potent anticancer efficacy"],"prefix":"10.1080","volume":"41","author":[{"given":"Wen","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xu","sequence":"additional","affiliation":[{"name":"Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Cui","sequence":"additional","affiliation":[{"name":"Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"12","key":"e_1_3_3_2_1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41580-021-00399-x","article-title":"Regulation of microtubule dynamics, mechanics and function through the growing tip","volume":"22","author":"Gudimchuk NB","year":"2021","unstructured":"Gudimchuk NB, McIntosh JR. Regulation of microtubule dynamics, mechanics and function through the growing tip. Nat Rev Mol Cell Biol. 2021;22(12):777\u2013795.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"e_1_3_3_3_1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41580-022-00473-y","article-title":"Mechanisms of microtubule organization in differentiated animal cells","volume":"23","author":"Akhmanova A","year":"2022","unstructured":"Akhmanova A, Kapitein LC. Mechanisms of microtubule organization in differentiated animal cells. Nat Rev Mol Cell Biol. 2022;23(8):541\u2013558.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5991","key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/312237a0","article-title":"Dynamic instability of microtubule growth","volume":"312","author":"Mitchison T","year":"1984","unstructured":"Mitchison T, Kirschner M. Dynamic instability of microtubule growth. Nature. 1984;312(5991):237\u2013242.","journal-title":"Nature"},{"issue":"10","key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"e2300210","DOI":"10.1002\/ardp.202300210","article-title":"Indole derivatives targeting colchicine binding site as potential anticancer agents","volume":"356","author":"Goel B","year":"2023","unstructured":"Goel B, Jaiswal S, Jain SK. Indole derivatives targeting colchicine binding site as potential anticancer agents. Arch Pharm (Weinheim). 2023;356(10):e2300210.","journal-title":"Arch Pharm (Weinheim)"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","first-page":"114614","DOI":"10.1016\/j.ejmech.2022.114614","article-title":"Novel fragment-derived colchicine-site binders as microtubule-destabilizing agents","volume":"241","author":"de la Roche NM","year":"2022","unstructured":"de la Roche NM, M\u00fchlethaler T, Di Martino RMC, Ortega JA, Gioia D, Roy B, Prota AE, Steinmetz MO, Cavalli A. Novel fragment-derived colchicine-site binders as microtubule-destabilizing agents. Eur J Med Chem. 2022;241:114614.","journal-title":"Eur J Med Chem"},{"issue":"15","key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4155\/fmc-2017-0100","article-title":"Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures","volume":"9","author":"Li W","year":"2017","unstructured":"Li W, Sun H, Xu S, Zhu Z, Xu J. Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures. Future Med Chem. 2017;9(15):1765\u20131794.","journal-title":"Future Med Chem"},{"issue":"11","key":"e_1_3_3_8_1","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2174\/0929867322666150114163732","article-title":"Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments","volume":"22","author":"Ji YT","year":"2015","unstructured":"Ji YT, Liu YN, Liu ZP. Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments. Curr Med Chem. 2015;22(11):1348\u20131360.","journal-title":"Curr Med Chem"},{"issue":"1","key":"e_1_3_3_9_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02940301","article-title":"Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines","volume":"26","author":"McGown AT","year":"1990","unstructured":"McGown AT, Fox BW. Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines. Cancer Chemother Pharmacol. 1990;26(1):79\u201381.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bcp.2012.06.005","article-title":"The vascular targeting agent Combretastatin-A4 directly induces autophagy in adenocarcinoma-derived colon cancer cells","volume":"84","author":"Greene LM","year":"2012","unstructured":"Greene LM, O\u2019Boyle NM, Nolan DP, Meegan MJ, Zisterer DM. The vascular targeting agent Combretastatin-A4 directly induces autophagy in adenocarcinoma-derived colon cancer cells. Biochem Pharmacol. 2012;84(5):612\u2013624.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s10637-014-0119-0","article-title":"Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin\/docetaxel or carboplatin\/paclitaxel in patients with advanced solid tumors","volume":"32","author":"Bahleda R","year":"2014","unstructured":"Bahleda R, Sessa C, Del Conte G, Gianni L, Capri G, Varga A, Oprea C, Daglish B, Hospitel M, Soria JC. Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin\/docetaxel or carboplatin\/paclitaxel in patients with advanced solid tumors. Invest New Drugs. 2014;32(6):1188\u20131196.","journal-title":"Invest New Drugs"},{"issue":"15","key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1158\/1078-0432.CCR-14-3370","article-title":"A phase I\/II Trial of BNC105P with everolimus in metastatic renal cell carcinoma","volume":"21","author":"Pal S","year":"2015","unstructured":"Pal S, Azad A, Bhatia S, Drabkin H, Costello B, Sarantopoulos J, Kanesvaran R, Lauer R, Starodub A, Hauke R, et al. A phase I\/II Trial of BNC105P with everolimus in metastatic renal cell carcinoma. Clin Cancer Res. 2015;21(15):3420\u20133427.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ejmech.2018.09.045","article-title":"Conformation impacts on the bioactivities of SMART analogues","volume":"158","author":"Wu Y","year":"2018","unstructured":"Wu Y, Guan Q, Zheng D, Yan P, Feng D, Du J, Zhang J, Zuo D, Bao K, Zhang W. Conformation impacts on the bioactivities of SMART analogues. Eur J Med Chem. 2018;158:733\u2013742.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s43188-022-00146-0","article-title":"CKD-516 potentiates the anti-cancer activity of docetaxel against epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer","volume":"39","author":"Kim SJ","year":"2023","unstructured":"Kim SJ, Lee K, Park J, Park M, Kim UJ, Kim SM, Ryu KH, Kang KW. CKD-516 potentiates the anti-cancer activity of docetaxel against epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer. Toxicol Res. 2023;39(1):61\u201369.","journal-title":"Toxicol Res"},{"issue":"32","key":"e_1_3_3_15_1","doi-asserted-by":"crossref","first-page":"29448","DOI":"10.1021\/acsomega.3c02979","article-title":"Effect of colchicine binding site inhibitors on the tubulin intersubunit interaction","volume":"8","author":"Sargsyan A","year":"2023","unstructured":"Sargsyan A, Sahakyan H, Nazaryan K. Effect of colchicine binding site inhibitors on the tubulin intersubunit interaction. ACS Omega. 2023;8(32):29448\u201329454.","journal-title":"ACS Omega"},{"issue":"10","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2174\/1871520616666160219161921","article-title":"Recent advances in heterocyclic tubulin inhibitors targeting the colchicine binding site","volume":"16","author":"Wu X","year":"2016","unstructured":"Wu X, Wang Q, Li W. Recent advances in heterocyclic tubulin inhibitors targeting the colchicine binding site. Anticancer Agents Med Chem. 2016;16(10):1325\u20131338.","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"e_1_3_3_17_1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/14756366.2021.1883598","article-title":"Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation","volume":"36","author":"Hagras M","year":"2021","unstructured":"Hagras M, El Deeb MA, Elzahabi HSA, Elkaeed EB, Mehany ABM, Eissa IH. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation. J Enzyme Inhib Med Chem. 2021;36(1):640\u2013658.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"6","key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/1535-7163.MCT-25-0559","article-title":"PM534, a novel colchicine\u2011site tubulin inhibitor with broad\u2011spectrum and resistance\u2011overcoming antitumor activity","volume":"25","author":"Aviles P","year":"2026","unstructured":"Aviles P, Ribeiro ML, Guill\u00e9n MJ, Martinez-Diez M, Mu\u00f1oz-Alonso MJ, Santamaria-Nu\u00f1ez G, Torralba D, Alamo P, Gallardo A, Oliva MA, et al. PM534, a novel colchicine\u2011site tubulin inhibitor with broad\u2011spectrum and resistance\u2011overcoming antitumor activity. Mol Cancer Ther. 2026;25Dec 31. (6):935\u2013947. Ahead of print.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"e_1_3_3_19_1","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bph.70294","article-title":"Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour efficacy in pancreatic cancer","volume":"183","author":"Wang R","year":"2026","unstructured":"Wang R, Cai C, Deng S, Xie Y, Pochampally S, Hamilton DJ, Meibohm B, Glazer ES, Miller DD, Li W. Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour efficacy in pancreatic cancer. Br J Pharmacol. 2026;183Dec 17. (9):2080\u20132098. Ahead of print.","journal-title":"Br J Pharmacol"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","first-page":"118395","DOI":"10.1016\/j.ejmech.2025.118395","article-title":"Synthesis and biological evaluation of polymethoxy homoisoflavanones as tubulin polymerization inhibitors","volume":"303","author":"Yin H","year":"2026","unstructured":"Yin H, Long J, Kong Y, Yin X, Liu Y, Xu Y, Nie Y, Liu X, Tang Y, Shi X, et al. Synthesis and biological evaluation of polymethoxy homoisoflavanones as tubulin polymerization inhibitors. Eur J Med Chem. 2026;303:118395.","journal-title":"Eur J Med Chem"},{"issue":"19","key":"e_1_3_3_21_1","doi-asserted-by":"crossref","first-page":"19908","DOI":"10.1021\/acs.jmedchem.5c00014","article-title":"Discovery of novel 4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one-based tubulin inhibitors targeting colchicine binding site with potent anti-ovarian cancer activity","volume":"68","author":"Yu Q","year":"2025","unstructured":"Yu Q, Liu Y, Wang Z, Wu C, Zhang R, Tan L, Zhang L, Guo C, Gou L, Li W, et al. Discovery of novel 4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one-based tubulin inhibitors targeting colchicine binding site with potent anti-ovarian cancer activity. J Med Chem. 2025;68(19):19908\u201319932.","journal-title":"J Med Chem"},{"issue":"12","key":"e_1_3_3_22_1","doi-asserted-by":"crossref","first-page":"e17086","DOI":"10.1002\/anie.202517086","article-title":"Coumarin-30 enables site-resolved detection of tubulin ligands by microscale thermophoresis","volume":"65","author":"Anisimov MN","year":"2026","unstructured":"Anisimov MN, Boichenko MA, Sivachev AA, Romanov AN, Lifshits IA, Borzunova JN, Janibekova M, Mustyatsa VV, Tikhonov TP, Plodukhin AY, et al. Coumarin-30 enables site-resolved detection of tubulin ligands by microscale thermophoresis. Angew Chem Int Ed Engl. 2026;65(12):e17086.","journal-title":"Angew Chem Int Ed Engl"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","first-page":"113826","DOI":"10.1016\/j.ejmech.2021.113826","article-title":"Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors","volume":"226","author":"Liu R","year":"2021","unstructured":"Liu R, Huang M, Zhang S, Li L, Li M, Sun J, Wu L, Guan Q, Zhang W. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors. Eur J Med Chem. 2021;226:113826.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"e_1_3_3_24_1","doi-asserted-by":"crossref","first-page":"118356","DOI":"10.1016\/j.ejmech.2025.118356","article-title":"Novel imidazo[1,2-a]pyridine-based tubulin polymerization inhibitors: Structure-activity relationships and anti-tumor immune potentiation","volume":"302","author":"Cheng B","year":"2026","unstructured":"Cheng B, Li C, Yang X, Wu Y, Ruan Y, Ren Y, Su Z, Wan S, Li X, Kong D, et al. Novel imidazo[1,2-a]pyridine-based tubulin polymerization inhibitors: Structure-activity relationships and anti-tumor immune potentiation. Eur J Med Chem. 2026;302(Pt 2):118356.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","first-page":"118405","DOI":"10.1016\/j.ejmech.2025.118405","article-title":"Design, synthesis, and biological evaluation of 2-(benzylthio)-5-(indol-3-yl)-1,3,4-oxadiazole derivatives as tubulin polymerization inhibitors with potential anti-cancer effects","volume":"303","author":"Yang B","year":"2026","unstructured":"Yang B, Man RJ, Xie Q, You J, Shi JY, Dai H, Zhu HL. Design, synthesis, and biological evaluation of 2-(benzylthio)-5-(indol-3-yl)-1,3,4-oxadiazole derivatives as tubulin polymerization inhibitors with potential anti-cancer effects. Eur J Med Chem. 2026;303:118405.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejmech.2018.11.070","article-title":"Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site","volume":"163","author":"Li W","year":"2019","unstructured":"Li W, Shuai W, Sun H, Xu F, Bi Y, Xu J, Ma C, Yao H, Zhu Z, Xu S. Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site. Eur J Med Chem. 2019;163:428\u2013442.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","first-page":"112105","DOI":"10.1016\/j.ejmech.2020.112105","article-title":"Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site","volume":"190","author":"Shao YY","year":"2020","unstructured":"Shao YY, Yin Y, Lian BP, Leng JF, Xia YZ, Kong LY. Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site. Eur J Med Chem. 2020;190:112105.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"e_1_3_3_28_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1021\/acsmedchemlett.9b00352","article-title":"Scaffold hopping-driven optimization of 4-(quinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-ones as novel tubulin inhibitors","volume":"11","author":"Jiang L","year":"2020","unstructured":"Jiang L, Goto M, Zhu DQ, Hsu PL, Li KP, Cui M, He X, Morris-Natschke SL, Lee KH, Xie L. Scaffold hopping-driven optimization of 4-(quinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-ones as novel tubulin inhibitors. ACS Med Chem Lett. 2020;11(1):83\u201389.","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"e_1_3_3_29_1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/acs.jmedchem.0c02064","article-title":"From synthetic simplified marine metabolite analogues to new selective allosteric inhibitor of aurora b kinase","volume":"64","author":"Juillet C","year":"2021","unstructured":"Juillet C, Ermolenko L, Boyarskaya D, Baratte B, Josselin B, Nedev H, Bach S, Iorga BI, Bignon J, Ruchaud S, et al. From synthetic simplified marine metabolite analogues to new selective allosteric inhibitor of aurora b kinase. J Med Chem. 2021;64(2):1197\u20131219.","journal-title":"J Med Chem"},{"issue":"7","key":"e_1_3_3_30_1","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/jm101582z","article-title":"Design and synthesis of imidazopyridine analogues as inhibitors of phosphoinositide 3-kinase signaling and angiogenesis","volume":"54","author":"Kim O","year":"2011","unstructured":"Kim O, Jeong Y, Lee H, Hong SS, Hong S. Design and synthesis of imidazopyridine analogues as inhibitors of phosphoinositide 3-kinase signaling and angiogenesis. J Med Chem. 2011;54(7):2455\u20132466.","journal-title":"J Med Chem"},{"issue":"11","key":"e_1_3_3_31_1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41573-023-00774-7","article-title":"Artificial intelligence for natural product drug discovery","volume":"22","author":"Mullowney MW","year":"2023","unstructured":"Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, Martin NI, Meijer D, Terlouw BR, Biermann F, Blin K, et al. Artificial intelligence for natural product drug discovery. Nat Rev Drug Discov. 2023;22(11):895\u2013916.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"e_1_3_3_32_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang K","year":"2025","unstructured":"Zhang K, Yang X, Wang Y, Yu Y, Huang N, Li G, Li X, Wu JC, Yang S. Artificial intelligence in drug development. Nat Med. 2025;31(1):45\u201359.","journal-title":"Nat Med"},{"issue":"4","key":"e_1_3_3_33_1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bmcl.2018.12.065","article-title":"Shape-based virtual screen for the discovery of novel CDK8 inhibitor chemotypes","volume":"29","author":"He LJ","year":"2019","unstructured":"He LJ, Zhu YB, Fan QZ, Miao DD, Zhang SP, Liu XP, Zhang C. Shape-based virtual screen for the discovery of novel CDK8 inhibitor chemotypes. Bioorg Med Chem Lett. 2019;29(4):549\u2013555.","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"e_1_3_3_34_1","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/acs.jmedchem.3c01093","article-title":"Discovery of novel aminobutanoic acid-based ASCT2 inhibitors for the treatment of non-small-cell lung cancer","volume":"67","author":"Qin L","year":"2024","unstructured":"Qin L, Cheng X, Wang S, Gong G, Su H, Huang H, Chen T, Damdinjav D, Dorjsuren B, Li Z, et al. Discovery of novel aminobutanoic acid-based ASCT2 inhibitors for the treatment of non-small-cell lung cancer. J Med Chem. 2024;67(2):988\u20131007.","journal-title":"J Med Chem"},{"issue":"19","key":"e_1_3_3_35_1","doi-asserted-by":"crossref","first-page":"17319","DOI":"10.1021\/acs.jmedchem.4c01223","article-title":"Discovery of novel PROTAC SIRT6 degraders with potent efficacy against hepatocellular carcinoma","volume":"67","author":"Huang J","year":"2024","unstructured":"Huang J, Su J, Wang H, Chen J, Tian Y, Zhang J, Feng T, Di L, Lu X, Sheng H, et al. Discovery of novel PROTAC SIRT6 degraders with potent efficacy against hepatocellular carcinoma. J Med Chem. 2024;67(19):17319\u201317349.","journal-title":"J Med Chem"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","first-page":"114846","DOI":"10.1016\/j.ejmech.2022.114846","article-title":"The SAR and action mechanisms of autophagy inhibitors that eliminate drug resistance","volume":"244","author":"Ye W","year":"2022","unstructured":"Ye W, Fan C, Fu K, Wang X, Lin J, Nian S, Liu C, Zhou W. The SAR and action mechanisms of autophagy inhibitors that eliminate drug resistance. Eur J Med Chem. 2022;244:114846.","journal-title":"Eur J Med Chem"},{"issue":"8","key":"e_1_3_3_37_1","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1021\/acs.jmedchem.0c02044","article-title":"Structure-enabled discovery of novel macrocyclic inhibitors targeting glutaminase 1 allosteric binding site","volume":"64","author":"Xu X","year":"2021","unstructured":"Xu X, Wang J, Wang M, Yuan X, Li L, Zhang C, Huang H, Jing T, Wang C, Tong C, et al. Structure-enabled discovery of novel macrocyclic inhibitors targeting glutaminase 1 allosteric binding site. J Med Chem. 2021;64(8):4588\u20134611.","journal-title":"J Med Chem"},{"issue":"15","key":"e_1_3_3_38_1","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1039\/D2SC06860E","article-title":"Discovery of a photoactivatable dimerized STING agonist based on the benzo[b]selenophene scaffold","volume":"14","author":"Liu D","year":"2023","unstructured":"Liu D, Yu B, Guan X, Song B, Pan H, Wang R, Feng X, Pan L, Huang H, Wang Z, et al. Discovery of a photoactivatable dimerized STING agonist based on the benzo[b]selenophene scaffold. Chem Sci. 2023;14(15):4174\u20134182.","journal-title":"Chem Sci"},{"key":"e_1_3_3_39_1","doi-asserted-by":"crossref","first-page":"140125","DOI":"10.1016\/j.molstruc.2024.140125","article-title":"Discovery of novel thiophene [2,3-D] pyrimidine-thiazole derivative as promising MNK inhibitor to treat breast cancer","volume":"1321","author":"Zhu P","year":"2025","unstructured":"Zhu P, Yang Y, Qian J, Han J, Kong D, Sun B, Zhang J, Wei J, Guo Q, Nian S, et al. Discovery of novel thiophene [2,3-D] pyrimidine-thiazole derivative as promising MNK inhibitor to treat breast cancer. J Mol Struct. 2025;1321:140125.","journal-title":"J Mol Struct"},{"issue":"1","key":"e_1_3_3_40_1","doi-asserted-by":"crossref","first-page":"114860","DOI":"10.1016\/j.ejmech.2022.114860","article-title":"Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors","volume":"245","author":"Zhou J","year":"2023","unstructured":"Zhou J, Yu LZ, Fan YL, Guo CH, Lv XM, Zhou ZY, Huang HD, Miao DD, Zhang SP, Li XY, et al. Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors. Eur J Med Chem. 2023;245(Pt 1):114860.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"e_1_3_3_41_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1039\/C3OB41798K","article-title":"The acid-catalysed synthesis of 7-azaindoles from 3-alkynyl-2-aminopyridines and their antimicrobial activity","volume":"12","author":"Leboho TC","year":"2014","unstructured":"Leboho TC, van Vuuren SF, Michael JP, de Koning CB. The acid-catalysed synthesis of 7-azaindoles from 3-alkynyl-2-aminopyridines and their antimicrobial activity. Org Biomol Chem. 2014;12(2):307\u2013315.","journal-title":"Org Biomol Chem"},{"issue":"21","key":"e_1_3_3_42_1","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.1021\/acs.jmedchem.5b01605","article-title":"A novel pyrazolopyridine with in vivo activity in plasmodium berghei- and plasmodium falciparum-infected mouse models from structure-activity relationship studies around the core of recently identified antimalarial imidazopyridazines","volume":"58","author":"Le Manach C","year":"2015","unstructured":"Le Manach C, Paquet T, Brunschwig C, Njoroge M, Han Z, Gonz\u00e0lez Cabrera D, Bashyam S, Dhinakaran R, Taylor D, Reader J, et al. A novel pyrazolopyridine with in vivo activity in plasmodium berghei- and plasmodium falciparum-infected mouse models from structure-activity relationship studies around the core of recently identified antimalarial imidazopyridazines. J Med Chem. 2015;58(21):8713\u20138722.","journal-title":"J Med Chem"},{"issue":"1","key":"e_1_3_3_43_1","doi-asserted-by":"crossref","first-page":"2302320","DOI":"10.1080\/14756366.2024.2302320","article-title":"Design, synthesis, and bioevaluation of 1H-pyrrolo[3,2-c]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities","volume":"39","author":"Wang C","year":"2024","unstructured":"Wang C, Zhang Y, Yang S, Shi L, Rong R, Zhang T, Wu Y, Xing D. Design, synthesis, and bioevaluation of 1H-pyrrolo[3,2-c]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities. J Enzyme Inhib Med Chem. 2024;39(1):2302320.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"e_1_3_3_44_1","doi-asserted-by":"crossref","first-page":"116869","DOI":"10.1016\/j.ejmech.2024.116869","article-title":"Discovery and biological evaluation of 6-aryl-4-(3,4,5-trimethoxyphenyl)quinoline derivatives with promising antitumor activities as novel colchicine-binding site inhibitors","volume":"279","author":"Xu Q","year":"2024","unstructured":"Xu Q, Tu Y, Zhang Y, Xiu Y, Yu Z, Jiang H, Wang C. Discovery and biological evaluation of 6-aryl-4-(3,4,5-trimethoxyphenyl)quinoline derivatives with promising antitumor activities as novel colchicine-binding site inhibitors. Eur J Med Chem. 2024;279:116869.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"e_1_3_3_45_1","doi-asserted-by":"crossref","first-page":"2595401","DOI":"10.1080\/14756366.2025.2595401","article-title":"Design, synthesis, and biological evaluation of novel 3-aryl-4-(3,4,5-trimethoxyphenyl)selenophene derivatives as new tubulin inhibitors","volume":"40","author":"Xu W","year":"2025","unstructured":"Xu W, Zhang Y, Xu Q, Zhao H, Gao Q, Zhao X, Jiang H, Wang C. Design, synthesis, and biological evaluation of novel 3-aryl-4-(3,4,5-trimethoxyphenyl)selenophene derivatives as new tubulin inhibitors. J Enzyme Inhib Med Chem. 2025;40(1):2595401.","journal-title":"J Enzyme Inhib Med Chem"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2686919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:24:56Z","timestamp":1781688296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2026.2686919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2026.2686919"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2026.2686919","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2686919"}}